- Home
- VCIG vs INM Comparison
VCIG vs INM Comparison
Compare VCIG & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCIG | INM |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | Malaysia | Canada |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.7M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | VCIG | INM |
|---|---|---|
| Price | $0.59 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 137.3K |
| Earning Date | 01-21-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.98 | N/A |
| Revenue | ★ $32,903,041.00 | $4,798,116.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.65 | ★ N/A |
| Revenue Growth | ★ 24.77 | N/A |
| 52 Week Low | $0.55 | $1.13 |
| 52 Week High | $1,290.00 | $8.27 |
Technical Indicators
Market Signals| Indicator | VCIG | INM |
|---|---|---|
| Relative Strength Index (RSI) | 32.36 | 40.67 |
| Support Level | $0.55 | $1.18 |
| Resistance Level | $0.68 | $1.35 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 7.51 | 24.94 |
Price Performance
Historical ComparisonAbout VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.